Sarah Rutherford
Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sarah Rutherford as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05994235 · Tazemetostat and Mosunetuzumab in Untreated Follicular LymphomaWeill Medical College of Cornell University · active not recruiting · Follicular Lymphoma · principal investigator
- Early Ph1NCT03585725 · A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell LymphomaWeill Medical College of Cornell University · terminated · Follicular Lymphoma, Mantle Cell Lymphoma · principal investigator
- Ph1NCT03036904 · Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell LymphomasWeill Medical College of Cornell University · completed · Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:20 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.N Engl J Med · 2024230 citationsRCR 27.8
- Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.Blood · 202365 citationsRCR 5.5
- Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients With First-Episode Psychosis Who Are Antipsychotic Naive.JAMA Psychiatry · 202232 citationsRCR 2.6
- Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.J Clin Oncol · 202532 citationsRCR 7.5
- Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma.Blood Adv · 202131 citationsRCR 1.6
- Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas.Leuk Lymphoma · 201528 citationsRCR 0.8
- Prophylactic intrapartum amnioinfusion for patients with oligohydramnios. A prospective randomized study.J Reprod Med · 199225 citationsRCR 1.4
- A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.Leuk Lymphoma · 201925 citationsRCR 0.8
- Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study.Lancet Haematol · 202124 citationsRCR 1.1
- Practical cooling interventions for preventing heat strain in indoor factory workers in Thailand.Am J Ind Med · 20248 citationsRCR 2.9